Impact of STEADI-Rx: A Community Pharmacy-Based Fall Prevention Intervention.
aging
community pharmacy
falls
health services
medication
Journal
Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
25
10
2019
revised:
06
02
2020
accepted:
13
03
2020
pubmed:
22
4
2020
medline:
3
3
2021
entrez:
22
4
2020
Statut:
ppublish
Résumé
To evaluate the effects of a community pharmacy-based fall prevention intervention (STEADI-Rx) on the risk of falling and use of medications associated with an increased risk of falling. Randomized controlled trial. A total of 65 community pharmacies in North Carolina (NC). Adults (age ≥65 years) using either four or more chronic medications or one or more medications associated with an increased risk of falling (n = 10,565). Pharmacy staff screened patients for fall risk using questions from the Stopping Elderly Accidents, Deaths, and Injuries (STEADI) algorithm. Patients who screened positive were eligible to receive a pharmacist-conducted medication review, with recommendations sent to patients' healthcare providers following the review. At intervention pharmacies, pharmacy staff used standardized forms to record participant responses to screening questions and information concerning the medication reviews. For participants with continuous Medicare Part D/NC Medicaid coverage (n = 3,212), the Drug Burden Index (DBI) was used to assess exposure to high-risk medications, and insurance claims records for emergency department visits and hospitalizations were used to assess falls. Among intervention group participants (n = 4,719), 73% (n = 3,437) were screened for fall risk. Among those who screened positive (n = 1,901), 72% (n = 1,373) received a medication review; and 27% (n = 521) had at least one medication-related recommendation communicated to their healthcare provider(s) following the review. A total of 716 specific medication recommendations were made. DBI scores decreased from the pre- to postintervention period in both the control and the intervention group. However, the amount of change over time did not differ between these two groups (P = .66). Risk of falling did not change between the pre- to postintervention period or differ between groups (P = .58). We successfully implemented STEADI-Rx in the community pharmacy setting. However, we found no differences in fall risk or the use of medications associated with increased risk of falling between the intervention and control groups. J Am Geriatr Soc 68:1778-1786, 2020.
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1778-1786Subventions
Organisme : NCIPC CDC HHS
ID : U01 CE002769
Pays : United States
Organisme : CDC HHS
ID : 1 U01 CE002769-01
Pays : United States
Informations de copyright
© 2020 The American Geriatrics Society.
Références
Bergen G, Stevens MR, Burns ER. Falls and fall injuries among adults aged ≥65 years-United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65:993-998.
US Preventive Services Task Force. USPSTF A and B Recommendations. December 2019. https://www.uspreventiveservicestaskforce.org/Page/Name/uspstf-a-and-b-recommendations/. Accessed February 3, 2020.
Hopewell S, Adedire O, Copsey BJ, et al. Multifactorial and multiple component interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2018;7:CD012221.
Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012;9:CD007146.
Summary of the updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc. 2010;59(1):148-157.
Stevens JA, Ballesteros MF, Mack KA, Rudd RA, DeCaro E, Adler G. Gender differences in seeking care for falls in the aged Medicare population. Am J Prev Med. 2012;43(1):59-62.
Wenger NS, Solomon DH, Roth CP, et al. The quality of medical care provided to vulnerable community-dwelling older patients. Ann Intern Med. 2003;139(9):740-747.
Sarmiento K, Lee R. STEADI: CDC's approach to make older adult fall prevention part of every primary care practice. J Safety Res. 2017;63:105-109.
Stevens JA, Phelan EA. Development of STEADI: a fall prevention resource for health care providers. Health Promot Pract. 2013;14(5):706-714.
Casey CM, Parker EM, Winkler G, Liu X, Lambert GH, Eckstrom E. Lessons learned from implementing CDC's STEADI falls prevention algorithm in primary care. Gerontologist. 2017;57(4):787-796.
Eckstrom E, Parker EM, Lambert GH, Winkler G, Dowler D, Casey CM. Implementing STEADI in academic primary care to address older adult fall risk. Innov Aging. 2017;1(2):igx028.
Johnston YA, Bergen G, Bauer M, et al. Implementation of the stopping elderly accidents, deaths, and injuries initiative in primary care: an outcome evaluation. Gerontologist. 2019;59(6):1182-1191.
Phelan EA, Aerts S, Dowler D, Eckstrom E, Casey CM. Adoption of evidence-based fall prevention practices in primary care for older adults with a history of falls. Front Public Health. 2016;4:190.
Wright DJ, Twigg MJ. Community pharmacy: an untapped patient data resource. Integr Pharm Res Pract. 2016;5:19-25.
Renfro CP, Urick BY, Mansour MA, Ferreri SP. Pharmacy characteristics correlating to performance in a community pharmacy network. J Am Pharm Assoc. 2019;59(2):275-279.
Robinson JM, Renfro CP, Shockley SJ, Blalock SJ, Watkins AK, Ferreri SP. Training and toolkit resources to support implementation of a community pharmacy fall prevention service. Pharmacy (Basel). 2019;7(3). pii: E113.
Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781-787.
Hilmer SN, Mager DE, Simonsick EM, et al. Drug burden index score and functional decline in older people. Am J Med. 2009;122(12):1142-1149.e1-e2.
Wilson NM, Hilmer SN, March LM, et al. Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc. 2011;59(5):875-880.
Gnjidic D, Bell JS, Hilmer SN, Lonnroos E, Sulkava R, Hartikainen S. Drug burden index associated with function in community-dwelling older people in Finland: a cross-sectional study. Ann Med. 2012;44(5):458-467.
Gnjidic D, Le Couteur DG, Abernethy DR, Hilmer SN. Drug burden index and Beers Criteria: impact on functional outcomes in older people living in self-care retirement villages. J Clin Pharmacol. 2012;52(2):258-265.
Gnjidic D, Le Couteur DG, Naganathan V, et al. Effects of drug burden index on cognitive function in older men. J Clin Psychopharmacol. 2012;32(2):273-277.
Lowry E, Woodman RJ, Soiza RL, Hilmer SN, Mangoni AA. Drug burden index, physical function, and adverse outcomes in older hospitalized patients. J Clin Pharmacol. 2012;52(10):1584-1591.
Jamsen KM, Bell JS, Hilmer SN, et al. Effects of changes in number of medications and drug burden index exposure on transitions between frailty states and death: the Concord Health and Ageing in Men Project cohort study. J Am Geriatr Soc. 2016;64(1):89-95.
Nishtala PS, Narayan SW, Wang T, Hilmer SN. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf. 2014;23(7):753-758.
Jamieson HA, Nishtala PS, Scrase R, et al. Drug burden and its association with falls among older adults in New Zealand: a National Population Cross-Sectional Study. Drugs Aging. 2018;35(1):73-81.
Jamieson HA, Nishtala PS, Scrase R, et al. Drug burden index and its association with hip fracture among older adults: a national population-based study. J Gerontol A Biol Sci Med Sci. 2019;74(7):1127-1133.
Byrne CJ, Walsh C, Cahir C, Bennett K. Impact of Drug Burden Index on adverse health outcomes in Irish community-dwelling older people: a cohort study. BMC Geriatr. 2019;19(1):121.
Min L, Tinetti M, Langa KM, Ha J, Alexander N, Hoffman GJ. Measurement of fall injury with health care system data and assessment of inclusiveness and validity of measurement models. JAMA Netw Open. 2019;2(8):e199679.
Pharmacy Quality Alliance. PQA medication therapy problem categories framework. https://www.pqaalliance.org/assets/Measures/PQA%20MTP%20Categories%20Framework.pdf. 2017. Accessed February 3, 2020.
Chronic Conditions Data Warehouse. Condition categories. https://www2.ccwdata.org/web/guest/condition-categories. Accessed October 18, 2019.
Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc. 1999;47:40-50.
Renfro CP, Turner K, Desai R, Counts J, Shea CM, Ferreri SP. Implementation process for comprehensive medication review in the community pharmacy setting. J Am Pharm Assoc. 2003;59(6):836-841.e2.